957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study
oleh: Manish Patel, Amita Patnaik, Ammar Sukari, Minal Barve, Mary Tagliaferri, Neha Dixit, Mehmet Altan, Christie Fanton, Xiaoli Wang, Sunil Sharma, Mario Marcondes, Sue Currie, Zachary Lee, Wildaliz Nieves, Haijun Ma, Lara Dunn, Patrick Cobb, Ari Rosenberg, Johnathan Zalevsky, Assuntina Sacco
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.